The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Small intestinal bacterial overgrowth in Parkinson's disease
Abstract
Background Recent studies reported a high prevalence of small intestinal bacterial overgrowth (SIBO) in Parkinson's disease (PD), and a possible association with gastrointestinal symptoms and worse motor function. We aimed to study the prevalence and the potential impact of SIBO on gastrointestinal symptoms, motor function, and quality of life in a large cohort of PD patients.Methods 103 Consecutive PD patients were assessed using the lactulose-hydrogen breath test; questionnaires of gastrointestinal symptoms and quality of life (PDQ-39); the Unified PD Rating Scale (UPDRS) including "on"-medication Part III (motor severity) score; and objective and quantitative measures of bradykinesia (Purdue Pegboard and timed test of gait). Patients and evaluating investigators were blind to SIBO status.Results 25.3% of PD patients were SIBO-positive. SIBO-positive patients had a shorter mean duration of PD (5.2 ± 4.1 vs. 8.1 ± 5.5 years, P = 0.007). After adjusting for disease duration, SIBO was significantly associated with lower constipation and tenesmus severity scores, but worse scores across a range of "on"-medication motor assessments (accounting for 4.2-9.0% of the variance in motor scores). There was no association between SIBO and motor fluctuations or PDQ-39 Summary Index scores.Conclusions This is the largest study to date on SIBO in PD. SIBO was detected in one quarter of patients, including patients recently diagnosed with the disease. SIBO was not associated with worse gastrointestinal symptoms, but independently predicted worse motor function. Properly designed treatment trials are needed to confirm a causal link between SIBO and worse motor function in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PD patients suffering from SIBO were not reported to develop worse GI dysfunction.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“However, they were independently predisposed to worse motor-dysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
In the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Tan et al., 2014
Citations
Cites
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
Nutl, J. G., & Fellman, J. H. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198403000-00002 · Cited by 357
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350
The role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 330
A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0065-1 · Cited by 323
Small intestinal bacterial overgrowth: a comprehensive review.
(2007) · PubMed Central · Cited by 321
Cited by
Sorted by citations
Items 101–200 of 274
Parkinson’s disease between internal medicine and neurology
Csóti, I., Jost, W. H., & Reichmann, H. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1443-z · Cited by 46
Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease
Anis, E., Xie, A., Brundin, L., & Brundin, P. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.11.005 · Cited by 40
Hasuike, Y., Endo, T., Koroyasu, M., Matsui, M., Mori, C., Yamadera, M., Fujimura, H., & Sakoda, S. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109436 · Cited by 42
Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?
Rao, S. S. C., Tan, G., Abdulla, H., Yu, S., Larion, S., & Leelasinjaroen, P. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0011-x · Cited by 41
The impact of indigenous microbes on Parkinson's disease
Sampson, T. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.014 · Cited by 41
Environmental factors in Parkinson’s disease: New insights into the molecular mechanisms
Yuan, X., Tian, Y., Liu, C., & Zhang, Z. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.12.003 · Cited by 42
van Kessel, S. P., Bullock, A., van Dijk, G., & El Aidy, S. (2022) · mSystems · doi:10.1128/msystems.01191-21 · Cited by 41
Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
Silva, D. F., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2022) · Antioxidants · doi:10.3390/antiox11112141 · Cited by 44
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
Ryman, S. G., Vakhtin, A. A., Richardson, S. P., & Lin, H. C. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11461-9 · Cited by 39
Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
Kang, Y., Kang, X., Zhang, H., Liu, Q., Yang, H., & Fan, W. (2021) · ASN NEURO · doi:10.1177/17590914211016217 · Cited by 38
Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
Ткач, С. М., Dorofeyev, A., Kuzenko, I., Boyko, N., Falalyeyeva, T. M., Boccuto, L., Scarpellini, E., Kobyliak, N. M., & Abenavoli, L. (2022) · Medicina · doi:10.3390/medicina58010084 · Cited by 39
Su, A., Gandhy, R., Barlow, C., & Triadafilopoulos, G. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000132 · Cited by 36
Wu, J., Li, C.-S., Huang, W., Zhou, S.-Y., Zhao, L., Li, T., Li, M., Zhang, M.-X., Qiao, C.-M., Zhao, W.-J., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.001 · Cited by 41
Wang, L., Yu, Y.-M., Zhang, Y.-Q., Zhang, J., Lu, N., & Liu, N. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1039-2 · Cited by 38
Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
Vizcarra, J. A., Wilson, H., Fasano, A. A., & Espay, A. J. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.04.003 · Cited by 37
Papel de la microbiota intestinal en el desarrollo de diferentes enfermedades neurológicas
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2019) · Neurología · doi:10.1016/j.nrl.2019.03.017 · Cited by 40
Effects of Helicobacter pylori on Levodopa Pharmacokinetics
Nyholm, D., & Hellström, P. M. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202298 · Cited by 38
Role of the gut microbiota in the development of various neurological diseases
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2021) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.03.026 · Cited by 40
Tan, A. H., Chuah, K. H., Beh, Y. Y., Schee, J. P., Mahadeva, S., & Lim, S. (2023) · Journal of Movement Disorders · doi:10.14802/jmd.22220 · Cited by 41
Kaur, S., Thukral, S. K., Kaur, P., & Samota, M. K. (2021) · Future Foods · doi:10.1016/j.fufo.2021.100043 · Cited by 37
Roszkowska, P., Klimczak, E., Ostrycharz, E., Rączka, A., Wojciechowska‐Koszko, I., Dybus, A., Cheng, Y.-H., Yu, Y., Mazgaj, S., & Hukowska-Szematowicz, B. (2024) · Biomedicines · doi:10.3390/biomedicines12051030 · Cited by 44
A role for microglia in mediating the microbiota–gut–brain axis
Keane, L., Clarke, G. A., & Cryan, J. F. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01188-9 · Cited by 43
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Bhatia, N. Y., Jalgaonkar, M. P., Hargude, A. B., Sherje, A. P., Oza, M. J., & Doshi, G. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220822172039 · Cited by 38
Gastrointestinal Dysfunction in Parkinson’s Disease
Safarpour, D., Sharzehi, K., & Pfeiffer, R. F. (2022) · Drugs · doi:10.1007/s40265-021-01664-1 · Cited by 36
Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
Hor, J. W., Lim, S., Khor, E.-S., Chong, K. K., Song, S., Ibrahim, N. M., Teh, C. S. J., Chong, C. W., Hilmi, I. N., & Tan, A. H. (2021) · Journal of Movement Disorders · doi:10.14802/jmd.21085 · Cited by 33
Kalampokini, S., Becker, A., Fassbender, K. C., Lyros, E., & Unger, M. M. (2019) · Parkinson s Disease · doi:10.1155/2019/7535472 · Cited by 34
Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression
Christine, C. W., Auinger, P., Saleh, N., Tian, M., Bottiglieri, T., Arning, E., Tran, N. K., Ueland, P. M., Green, R., & the Parkinson Study Group—DATATOP Investigators (2020) · Movement Disorders · doi:10.1002/mds.28073 · Cited by 30
A review of studies on gut microbiota and levodopa metabolism
Zhong, Z., Ye, M., & Yan, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1046910 · Cited by 31
Chaiwiang, N., & Poyomtip, T. (2019) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.66.2019.038 · Cited by 29
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
Dănău, A., Dumitrescu, L., Lefter, A., Tulbă, D., & Popescu, B. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111663 · Cited by 30
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 27
Aetiology, diagnosis and management of small intestinal bacterial overgrowth
Ahmed, J. F., Padam, P., & Ruban, A. (2023) · Frontline Gastroenterology · doi:10.1136/flgastro-2022-102163 · Cited by 28
Bhidayasiri, R., Phuenpathom, W., Tan, A. H., Leta, V., Phumphid, S., Chaudhuri, К. R., & Pal, P. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979826 · Cited by 28
Wang, W., Jiang, S., Xu, C., Tang, L., Liang, Y., Zhao, Y., & Zhu, G. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.976316 · Cited by 29
Ilie, O., Ciobica, A. S., McKenna, J., Doroftei, B., & Mavroudis, I. A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4518023 · Cited by 29
Dietiker, C., Kim, S., Zhang, Y., & Christine, C. W. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18049 · Cited by 25
Laterality in Parkinson’s disease: A neuropsychological review
Steinbach, M. J., Campbell, R. W., DeVore, B. B., & Harrison, D. W. (2021) · Applied Neuropsychology Adult · doi:10.1080/23279095.2021.1907392 · Cited by 28
Pagano, G., Yousaf, T., Wilson, H., Niccolini, F., Polychronis, S., Chaudhuri, К. R., & Politis, M. (2017) · European Journal of Neurology · doi:10.1111/ene.13503 · Cited by 25
Patil, R. S., & Tupe, R. S. (2023) · Medicinal Research Reviews · doi:10.1002/med.21987 · Cited by 23
A neuroscience perspective of the gut theory of Parkinson's disease
Smith, L. M., & Parr‐Brownlie, L. C. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13869 · Cited by 25
Fu, J., Li, Z., Wang, F., & Yu, K. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1948655 · Cited by 23
Parkinson's disease: Are gut microbes involved?
Omotosho, A. O., Tajudeen, Y. A., Oladipo, H. J., Yusuff, S. I., Abdulkadir, M., Muili, A. O., Egbewande, O. M., Yusuf, R. O., Faniran, Z. O., Afolabi, A. O., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3130 · Cited by 24
Management of Gastrointestinal Symptoms in Parkinson’s Disease
Pasricha, T. S., Guerrero-López, I., & Kuo, B. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001961 · Cited by 25
Small intestinal bacterial overgrowth in Alzheimer’s disease
Kowalski, K., & Mulak, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02440-x · Cited by 19
Deng, L., Liu, Y., Zhang, D., LI, Y., & Xu, L. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.807 · Cited by 20
Weight Loss in Parkinson’s Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth
DiBaise, J. K., Crowell, M. D., Driver‐Dunckley, E. D., Mehta, S. H., Hoffman‐Snyder, C., Lin, T. P., & Adler, C. H. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181386 · Cited by 19
Liu, X., Liu, S., Tang, Y., Pu, Z., Xiao, H., Gao, J., Yin, Q., Jia, Y., & Bai, Q. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03293-2 · Cited by 18
Cabral, G. F., Schaan, A. P., Cavalcante, G. C., Sena-dos-Santos, C., de Souza, T. P., Port’s, N. M. D. S., Pinheiro, J. A. D. S., Ribeiro‐dos‐Santos, Â., & Vidal, A. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189839 · Cited by 18
The gastrointestinal tract and Parkinson’s disease
Higinbotham, A. S., & Kilbane, C. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1158986 · Cited by 22
Cheng, X., Zhang, L., Xie, N., Xu, H. ‐., & Lian, Y. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13583 · Cited by 18
Zhang, Z., & Chen, S. (2020) · Parkinson s Disease · doi:10.1155/2020/8740732 · Cited by 18
The Role of The Gut Microbiome in Parkinson’s Disease
Gallop, A., Weagley, J. S., Paracha, S.-U.-R., & Grossberg, G. T. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211018268 · Cited by 18
Gastrointestinal dysfunction in the synucleinopathies
Chung, K. A., & Pfeiffer, R. F. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00745-7 · Cited by 17
The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine
van Laar, T., & Borgemeester, R. W. K. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.11.019 · Cited by 17
Parkinson Disease and the Gut: A Primer for Gastroenterologists
Sharma, A., Voigt, R. M., Goetz, C. G., & Keshavarzian, A. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003508 · Cited by 17
The Gut-Brain Axis in Alzheimer’s Disease: Exploring Microbial Influences and Therapeutic Strategies
Mustafa, M. A., Vadia, N., Varma, P., Al‐Shaker, H., Mohanty, B., Dhyani, A., Kaur, I., Chauhan, A. S., & Garg, G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05474-4 · Cited by 18
Hosseininasab, S. S. M., Ebrahimi, R., Yaghoobpoor, S., Kazemi, K., Khakpour, Y., Hajibeygi, R., Mohamadkhani, A., Fathi, M., Vakili, K. G., Tavasol, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1513095 · Cited by 20
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Zhang, Y., Mo, C., Ai, P., He, X., Xiao, Q., & Yang, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2454937 · Cited by 20
Modica, J. S., Déry, C., Canissario, R., Logigian, E. L., Bonno, D., Stanton, M., Dupré, N., McDermott, M., Bouchard, M., Lang, A. E., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120690 · Cited by 15
Zhang, Y., Liu, G., Duan, Y., Han, X., Dong, H., & Geng, J. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.11.004 · Cited by 15
Association between small intestinal bacterial overgrowth and deep vein thrombosis
Fialho, A., Fialho, A. B. C., Schenone, A. L., Thota, P. N., McCullough, A. J., & Shen, B. (2016) · Gastroenterology report · doi:10.1093/gastro/gow004 · Cited by 15
Zhang, R., Feng, R., Wang, J., Chen, Y., Liu, H., Zhu, Q., Tian, H., Qin, C., Teng, J., Tang, B., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02604-9 · Cited by 14
Procedural Learning in Children With Developmental Coordination, Reading, and Attention Disorders
Magallón, S., Crespo-Eguílaz, N., & Narbona, J. (2015) · Journal of Child Neurology · doi:10.1177/0883073815572227 · Cited by 14
Bai, F., & Li, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119767 · Cited by 14
Flanagan, R., Rusch, C. T., Lithander, F. E., & Subramanian, I. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106021 · Cited by 14
Andriolo, I. R. L., Longo, B. C., de Melo, D. M., de Souza, M. M., Prediger, R. D., & da Silva, L. M. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273289138240306050532 · Cited by 15
Association between small intestine bacterial overgrowth and psychiatric disorders
Bogielski, B., Michalczyk, K., Głodek, P., Tempka, B., Gębski, W., & Stygar, D. M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1438066 · Cited by 14
Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?
Rajput, C., Sarkar, A., Sachan, N., Rawat, N., & Singh, M. P. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03187-9 · Cited by 13
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Guo, T., & Chen, L. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221083763 · Cited by 14
Ai, P., Xu, S., Yuan, Y., Xu, Z., He, X., Mo, C., Zhang, Y., Yang, X., & Xiao, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115282 · Cited by 14
Shamsdin, S. A., Khazraei, H., Jaberi, A. R., Zamani, M., & Monjezi, M. R. (2022) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2022.261 · Cited by 12
Angiotensin (1–7) Expressing Probiotic as a Potential Treatment for Dementia
Hernandez, A. R., Banerjee, A., Carter, C. S., & Buford, T. W. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.629164 · Cited by 12
Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease
Olubodun-Obadun, T. G., Ishola, I. O., & Adeyemi, O. O. (2022) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2021-0144 · Cited by 13
Microbiome and motor neuron diseases
Chatterjee, K., & Banerjee, S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.010 · Cited by 12
The gut-brain axis in the pathogenesis of Parkinson’s disease
Meng, L., Yuan, X., Cao, X., & Zhang, Z. (2019) · Brain Science Advances · doi:10.1177/2096595820902566 · Cited by 12
The Microbiome–Neurodegeneration Interface: Mechanisms, Evidence, and Future Directions
Böckels, L., Alexa, D., Antal, D. C., Gațcan, C., Alecu, C., Kacani, K., Cretu, R. A., Piseru, E.-A., Bîlcu, R. V., & Cuciureanu, D. I. (2026) · Cells · doi:10.3390/cells15020135 · Cited by 13
Moreno, L. O., Bagüés, A., Martínez, V., & Abalo, R. (2023) · Nutrients · doi:10.3390/nu15122775 · Cited by 11
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Kishanchand, D. K., A., A. K. K., Chandrababu, K., Philips, C. A., Sivan, U., & Chakrapani, P. S. B. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70016 · Cited by 13
Gut-oriented disease modifying therapy for Parkinson's disease
Lin, C., Lai, H., & Wu, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.09.010 · Cited by 11
Gut microbiota in Parkinson’s disease patients: hospital-based study
Khedr, E. M., Ali, A. M., Daef, E., Hassan, H. M., Alaa, A., & Gamea, A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00407-z · Cited by 11
Non-Oral Drug Delivery in Parkinson’s Disease: Current Applications and Future
Güneş, M., & Karavana, S. Y. (2021) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2021.95226 · Cited by 14
Tucker, R. M., Ryan, S., Hayee, B., Bjarnason, I., Augustin, A. D., Umamahesan, C., Taylor, D. M., Weller, C., Dobbs, S. M., Dobbs, R. J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061916 · Cited by 10
Faecal microbiota transplant for Parkinson’s disease: promises and future directions
Tan, E. K., Wang, J. D. J., Pettersson, S., Wang, Q., Takahashi, R., Poewe, W. H., Jankovic, J. J., & Rascol, O. (2025) · Brain · doi:10.1093/brain/awaf419 · Cited by 10
Dopamine and Gastrointestinal Motility
Zheng, L., Liu, S., Zhou, L., Zhang, X., Xiao, Y., & Zhu, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6586-5_5 · Cited by 9
Disease mechanisms as subtypes: Microbiome
Bonvegna, S., & Cilia, R. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00006-0 · Cited by 8
Wu, L., Chu, L., Cao, H., Tian, Q., Gao, H., Huo, J., & Gao, Q. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103548 · Cited by 8
An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes
Talman, L. S., & Safarpour, D. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771461 · Cited by 8
Morais, L. H., Stiles, L., Freeman, M., Oguienko, A. D., Hoang, J. D., Ji, J., Jones, J. J., Quan, B., Devine, J., Bois, J. S., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01142-5 · Cited by 9
Chen, H.-L., Lei, W., Wang, J., Bair, M., & Chen, C. (2023) · Medicine · doi:10.1097/md.0000000000033711 · Cited by 7
The Thermodynamic Consequences of Parkinson's Disease
Kempster, P. A., & Perju‐Dumbrava, L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.685314 · Cited by 8
Chang, J. J., Gadi, S. R. V., Videnović, A., Kuo, B., & Pasricha, T. S. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2023.100215 · Cited by 7
Radisavljevic, N., Metcalfe‐Roach, A., Cirstea, M. S., Tabusi, M., Bozorgmehr, T., Bar‐Yoseph, H., & Finlay, B. B. (2023) · mSphere · doi:10.1128/msphere.00379-23 · Cited by 10
Moiseyenko, A., Antonello, G., Schonhoff, A. M., Boktor, J. C., Long, K., Dirks, B., Oguienko, A. D., Winnett, A. V., Simpson, P., Daeizadeh, D., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01287-x · Cited by 8
Вячеславович, К. И., Litvinenko, I., Родионов, Г. Г., Игнатьевич, Ш. И., & Светкина, Е. В. (2018) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2018.4.3 · Cited by 6
Early-morning OFF in Parkinson’s disease: A systematic literature review and current therapeutics
Kataoka, H., & Sugie, K. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108493 · Cited by 6
Hernandez, A. R., Hoffman, J. M., Hernandez, C. M., Cortés, C. J., Jumbo-Lucioni, P., Baxter, M. G., Esser, K. A., Liu, A. C., McMahon, L. L., Bizon, J. L., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab215 · Cited by 9
Cui, X., Guo, H., Liu, Z., Lei, Y., Wei, Y., Sun, G., Zhang, D., Hao, J., Zhang, D., & Liu, X. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.06.008 · Cited by 5
Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis
Damianos, J., Wang, X. J., & Camilleri, M. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00295-x · Cited by 5
The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease
Justich, M. B., Rojas, O. L., & Fasano, A. A. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771468 · Cited by 5
Khosravi, F., Mirzaei, S., Hojati, V., Hashemi, M., & Entezari, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03186-7 · Cited by 5
Metadata
- Authors
- Tan, A. H., Mahadeva, S., Thalha, A. M., Gibson, P. R., Kiew, C. K., Yeat, C. M., Ng, S. W., Ang, S. P., Chow, S. K., Tan, C. T., Yong, H. S., Marras, C., Fox, S. H., & Lim, S.-Y.
- Affiliations
- University of Malaya (MY)
- The Alfred Hospital (AU)
- University of Toronto (CA)
- Corresponding author
- Lim, Shen-Yang
- ORCID
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 20
- Issue
- 5
- Pages
- 535-540
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W1983564695
- Cited by
- 274
- References
- 34
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 39 · 2020: 34 · 2019: 25 · 2018: 28 · 2017: 20 · 2016: 11 · 2015: 15 · 2014: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Malaysian Ministry of Higher Education
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- small intestinal bacterial overgrowth, Parkinson's disease
- MeSH terms
- Aged, Bacterial Infections, Female, Humans, Hydrogen, Intestinal Diseases, Lactulose, Male, Middle Aged, Parkinson Disease, Quality of Life, Surveys and Questionnaires, Regression Analysis, Severity of Illness Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review